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Teaser: Our review found the average R0 for COVID-19 to be 3.28, which exceeds WHO estimates from 1.4 to 2.5.
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Introduction
In Wuhan, China, a novel and alarmingly contagious primary
atypical (viral) pneumonia broke out in December 2019. It has
since been identified as a zoonotic coronavirus, similar to SARS
coronavirus and MERS coronavirus and named COVID-19. As
of 8 February 2020, 33 738 confirmed cases and 811 deaths have
been reported in China.
Here we review the basic reproduction number (R0) of the
COVID-19 virus. R0 is an indication of the transmissibility of a
virus, representing the average number of new infections gener-
ated by an infectious person in a totally naïve population. For
R0 > 1, the number infected is likely to increase, and for R0 < 1,
transmission is likely to die out. The basic reproduction number
is a central concept in infectious disease epidemiology, indicating
the risk of an infectious agent with respect to epidemic spread.
Methods and Results
PubMed, bioRxiv and Google Scholar were accessed to search
for eligible studies. The term ‘coronavirus & basic reproduction
number’ was used. The time period covered was from 1 January
2020 to 7 February 2020. For this time period, we identified
12 studies which estimated the basic reproductive number for
COVID-19 from China and overseas. Table 1 shows that the
estimates ranged from 1.4 to 6.49,with a mean of 3.28, a median
of 2.79 and interquartile range (IQR) of 1.16.
The first studies initially reported estimates of R0 with
lower values. Estimations subsequently increased and then again
returned in the most recent estimates to the levels initially
reported (Figure 1). A closer look reveals that the estimation
method used played a role.
The two studies using stochastic methods to estimate R0,
reported a range of 2.2–2.68 with an average of 2.44.1 , 9 The six
studies using mathematical methods to estimate R0 produced a
range from 1.5 to 6.49,with an average of 4.2.2 , 4–6 , 8 , 10 The three
studies using statistical methods such as exponential growth
estimated an R0 ranging from 2.2 to 3.58, with an average of
2.67.3 , 7 , 11
Discussion
Our review found the average R0 to be 3.28 and median to
be 2.79, which exceed WHO estimates from 1.4 to 2.5. The
studies using stochastic and statistical methods for deriving R0
provide estimates that are reasonably comparable. However, the
studies using mathematical methods produce estimates that are,
on average, higher. Some of the mathematically derived estimates
fall within the range produced the statistical and stochastic
estimates. It is important to further assess the reason for the
higher R0 values estimated by some the mathematical studies.
For example, modelling assumptions may have played a role. In
more recent studies, R0 seems to have stabilized at around 2–3.
R0 estimations produced at later stages can be expected to be
more reliable, as they build upon more case data and include the
effect of awareness and intervention. It is worthy to note that
the WHO point estimates are consistently below all published
estimates, although the higher end of the WHO range includes
the lower end of the estimates reviewed here.
R0 estimates for SARS have been reported to range between
2 and 5, which is within the range of the mean R0 for COVID-
19 found in this review. Due to similarities of both pathogen
and region of exposure, this is expected. On the other hand,
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Table 1. Published estimates of R0 for 2019-nCoV
Study
(study year)
Location Study date Methods Approaches R0 estimates
(average)
95%
CI
Joseph et al.1 Wuhan 31 December
2019–28 January
2020
Stochastic Markov Chain
Monte Carlo methods (MCMC)
MCMC methods with Gibbs
sampling and non-informative
flat prior, using posterior
distribution
2.68 2.47–2.86
Shen et al.2 Hubei
province
12–22 January
2020
Mathematical model, dynamic
compartmental model with
population divided into five
compartments: susceptible
individuals, asymptomatic
individuals during the
incubation period, infectious
individuals with symptoms,
isolated individuals with
treatment and recovered
individuals
R0 = β/α
β = mean person-to-person
transmission rate/day in the
absence of control interventions,
using nonlinear least squares
method to get its point estimate
α = isolation rate = 6
6.49 6.31–6.66
Liu et al.3 China and
overseas
23 January 2020 Statistical exponential Growth,
using SARS generation
time=8.4 days, SD=3.8 days
Applies Poisson regression to fit
the exponential growth rate
R0 =1/M(−r)
M=moment generating
function of the generation
time distribution
r= fitted exponential
growth rate
2.90 2.32–3.63
Liu et al.3 China and
overseas
23 January 2020 Statistical maximum likelihood
estimation, using SARS
generation time=8.4 days,
SD=3.8 days
Maximize log-likelihood to
estimate R0 by using
surveillance data during a
disease epidemic, and assuming
the secondary case is Poisson
distribution with expected
value R0
2.92 2.28–3.67
Read et al.4 China 1–22 January 2020 Mathematical transmission
model assuming latent
period=4 days and near to the
incubation period
Assumes daily time increments
with Poisson-distribution and
apply a deterministic SEIR
metapopulation transmission
model, transmission rate=1.94,
infectious period =1.61 days
3.11 2.39–4.13
Majumder
et al.5
Wuhan 8 December 2019
and 26 January
2020
Mathematical Incidence Decay
and Exponential Adjustment
(IDEA) model
Adopted mean serial interval
lengths from SARS and MERS
ranging from 6 to 10 days to fit
the IDEA model,
2.0–3.1
(2.55)
/
WHO China 18 January 2020 / / 1.4–2.5
(1.95)
/
Cao et al.6 China 23 January 2020 Mathematical model including
compartments
Susceptible-Exposed-Infectious-
Recovered-Death-Cumulative
(SEIRDC)
R = K 2 (L × D) +
K(L + D)+1
L= average latent period=7,
D= average latent infectious
period=9,
K= logarithmic growth rate of
the case counts
4.08 /
Zhao et al.7 China 10–24 January
2020
Statistical exponential growth
model method adopting serial
interval from SARS
(mean=8.4 days,
SD=3.8 days) and MERS
(mean=7.6 days,
SD=3.4 days)
Corresponding to 8-fold
increase in the reporting rate
R0 =1/M(−r)
r =intrinsic growth rate
M=moment generating
function
2.24 1.96–2.55
(continued)
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Table 1. Continued
Study
(study year)
Location Study date Methods Approaches R0 estimates
(average)
95%
CI
Zhao et al.7 China 10–24 January
2020
Statistical exponential growth
model method adopting serial
interval from SARS
(mean=8.4 days,
SD=3.8 days) and MERS
(mean=7.6 days,
SD=3.4 days)
Corresponding to 2-fold
increase in the reporting rate
R0 =1/M(−r)
r =intrinsic growth rate
M=moment generating
function
3.58 2.89–4.39
Imai (2020)8 Wuhan January 18, 2020 Mathematical model,
computational modelling of
potential epidemic trajectories
Assume SARS-like levels of
case-to-case variability in the
numbers of secondary cases and
a SARS-like generation time
with 8.4 days, and set number
of cases caused by zoonotic
exposure and assumed total
number of cases to estimate R0
values for best-case, median and
worst-case
1.5–3.5 (2.5) /
Julien and
Althaus9
China and
overseas
18 January 2020 Stochastic simulations of early
outbreak trajectories
Stochastic simulations of early
outbreak trajectories were
performed that are consistent
with the epidemiological
findings to date
2.2
Tang et al.10 China 22 January 2020 Mathematical SEIR-type
epidemiological model
incorporates appropriate
compartments corresponding to
interventions
Method-based method and
Likelihood-based method
6.47 5.71–7.23
Qun Li
et al.11
China 22 January 2020 Statistical exponential growth
model
Mean incubation
period=5.2 days, mean serial
interval=7.5 days
2.2 1.4–3.9
Averaged 3.28
CI, Confidence interval.
Figure 1. Timeline of the R0 estimates for the 2019-nCoV virus in China
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despite the heightened public awareness and impressively
strong interventional response, the COVID-19 is already
more widespread than SARS, indicating it may be more
transmissible.
Conclusions
This review found that the estimated mean R0 for COVID-19
is around 3.28, with a median of 2.79 and IQR of 1.16, which
is considerably higher than the WHO estimate at 1.95. These
estimates of R0 depend on the estimation method used as well
as the validity of the underlying assumptions. Due to insufficient
data and short onset time, current estimates of R0 for COVID-
19 are possibly biased. However, as more data are accumulated,
estimation error can be expected to decrease and a clearer picture
should form. Based on these considerations,R0 for COVID-19 is
expected to be around 2–3, which is broadly consistent with the
WHO estimate.
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